본문 바로가기
KERD
논문KCI 등재

Oxidized LDL Accelerates Cartilage Destruction and Inflammatory Chondrocyte Death in Osteoarthritis by Disrupting the TFEB-Regulated Autophagy-Lysosome Pathway

김석중|조미라|Jeong Won Choi|전주연|나현식|Seung Hyo Kim|Yun Hwan Kim|Jin Seok Woo|이정수|In Gyu Um|Asode Ananthram Shetty
대한면역학회 (The Korean Association of Immunologists)|2024.06|Immune Network|제24권 제3호|pp. 1-18|DOI 10.4110/in.2024.24.e15

1

조회

0

다운로드

0

인용

0

참고문헌

키워드

OsteoarthritisDyslipidemiaAutophagyNecroptosisLow-density lipoprotein

초록

Osteoarthritis (OA) involves cartilage degeneration, thereby causing inflammation and pain. Cardiovascular diseases, such as dyslipidemia, are risk factors for OA; however, the mechanism is unclear. We investigated the effect of dyslipidemia on the development of OA. Treatment of cartilage cells with low-density lipoprotein (LDL) enhanced abnormal autophagy but suppressed normal autophagy and reduced the activity of transcription factor EB (TFEB), which is important for the function of lysosomes. Treatment of LDL-exposed chondrocytes with rapamycin, which activates TFEB, restored normal autophagy. Also, LDL enhanced the inflammatory death of chondrocytes, an effect reversed by rapamycin. In an animal model of hyperlipidemia-associated OA, dyslipidemia accelerated the development of OA, an effect reversed by treatment with a statin, an anti-dyslipidemia drug, or rapamycin, which activates TFEB. Dyslipidemia reduced the autophagic flux and induced necroptosis in the cartilage tissue of patients with OA. The levels of triglycerides, LDL, and total cholesterol were increased in patients with OA compared to those without OA. The C-reactive protein level of patients with dyslipidemia was higher than that of those without dyslipidemia after total knee replacement arthroplasty. In conclusion, oxidized LDL, an important risk factor of dyslipidemia, inhibited the activity of TFEB and reduced the autophagic flux, thereby inducing necroptosis in chondrocytes.

Abstract

Osteoarthritis (OA) involves cartilage degeneration, thereby causing inflammation and pain. Cardiovascular diseases, such as dyslipidemia, are risk factors for OA; however, the mechanism is unclear. We investigated the effect of dyslipidemia on the development of OA. Treatment of cartilage cells with low-density lipoprotein (LDL) enhanced abnormal autophagy but suppressed normal autophagy and reduced the activity of transcription factor EB (TFEB), which is important for the function of lysosomes. Treatment of LDL-exposed chondrocytes with rapamycin, which activates TFEB, restored normal autophagy. Also, LDL enhanced the inflammatory death of chondrocytes, an effect reversed by rapamycin. In an animal model of hyperlipidemia-associated OA, dyslipidemia accelerated the development of OA, an effect reversed by treatment with a statin, an anti-dyslipidemia drug, or rapamycin, which activates TFEB. Dyslipidemia reduced the autophagic flux and induced necroptosis in the cartilage tissue of patients with OA. The levels of triglycerides, LDL, and total cholesterol were increased in patients with OA compared to those without OA. The C-reactive protein level of patients with dyslipidemia was higher than that of those without dyslipidemia after total knee replacement arthroplasty. In conclusion, oxidized LDL, an important risk factor of dyslipidemia, inhibited the activity of TFEB and reduced the autophagic flux, thereby inducing necroptosis in chondrocytes.

참고문헌 (45)

  1. Hashimoto K, "The role of oxidation of low-density lipids in pathogenesis of osteoarthritis : a narrative review", J Int Med Res, 48, pp.300060520931609~ (2020)
  2. de Munter W, "Cholesterol accumulation caused by low density lipoprotein receptor deficiency or a cholesterol-rich diet results in ectopic bone formation during experimental osteoarthritis", Arthritis Res Ther, 15, pp.R178~ (2013)
  3. Akkiraju H, "Role of chondrocytes in cartilage formation, progression of osteoarthritis and cartilage regeneration", J Dev Biol, 3, pp.177~192 (2015)
  4. Rellmann Y, "Review : ER stress-induced cell death in osteoarthritic cartilage", Cell Signal, 78, pp.109880~ (2021)
  5. Dai W, "The potential role of necroptosis in clinical diseases(review)", Int J Mol Med, 47, pp.1~16 (2021)
  6. Duan R, "The role of autophagy in osteoarthritis", Front Cell Dev Biol, 8, pp.608388~ (2020)
  7. Funck-Brentano T, "Causal factors for knee, hip, and hand osteoarthritis : a Mendelian randomization study in the UK Biobank", Arthritis Rheumatol, 71, pp.1634~1641 (2019)
  8. Linton MF, "Endotext" (2000), MDText.com, Inc
  9. Nemet M, "Association between metabolic syndrome, its components, and knee osteoarthritis in premenopausal and menopausal women : a pilot study", Cureus, 14, pp.e26726~ (2022)
  10. Fang Z, "Overactivation of hepatic mechanistic target of rapamycin kinase complex 1(mTORC1)is associated with low transcriptional activity of transcription factor EB and lysosomal dysfunction in dairy cows with clinical ketosis", J Dairy Sci, 105, pp.4520~4533 (2022)
  11. Schwager JL, "Association of serum low-density lipoprotein, high-density lipoprotein, and total cholesterol with development of knee osteoarthritis", Arthritis Care Res(Hoboken), 74, pp.274~280 (2022)
  12. Nakagawa T, "LOX-1 expressed in cultured rat chondrocytes mediates oxidized LDL-induced cell death-possible role of dephosphorylation of Akt", Biochem Biophys Res Commun, 299, pp.91~97 (2002)
  13. Hashimoto K, "Lectin-like, oxidized low-density lipoprotein receptor-1-deficient mice show resistance to age-related knee osteoarthritis", Eur J Histochem, 61, pp.2762~ (2017)
  14. Akagi M, "Possible involvement of the oxidized low-density lipoprotein", lectin-like oxidized low-density lipoprotein receptor-1 system in pathogenesis and progression of human osteoarthritis, 2007, pp.15, 281~290
  15. Cao C, "Cholesterol-induced LRP3 downregulation promotes cartilage degeneration in osteoarthritis by targeting Syndecan-4", Nat Commun, 13, pp.7139~ (2022)
  16. Choi WS, "The CH25H-CYP7B1-RORα axis of cholesterol metabolism regulates osteoarthritis", Nature, 566, pp.254~258 (2019)
  17. Shen P, "Oxidized low density lipoprotein facilitates tumor necrosis factor-α mediated chondrocyte death via autophagy pathway", Mol Med Rep, 16, pp.9449~9456 (2017)
  18. Luo P, "The role of autophagy in chondrocyte metabolism and osteoarthritis : a comprehensive research review", BioMed Res Int, 2019, pp.5171602~ (2019)
  19. Caramés B, "Autophagy is a protective mechanism in normal cartilage, and its aging-related loss is linked with cell death and osteoarthritis", Arthritis Rheum, 62, pp.791~801 (2010)
  20. Sun K, "Inhibition of TRADD ameliorates chondrocyte necroptosis and osteoarthritis by blocking RIPK1-TAK1 pathway and restoring autophagy", Cell Death Dis, 9, pp.109~ (2023)
  21. Zhang H, "Augmenting ATG14 alleviates atherosclerosis and inhibits inflammation via promotion of autophagosome-lysosome fusion in macrophages", Autophagy, 17, pp.4218~4230 (2021)
  22. Qin X, "Inhibition of Connexin 43 reverses ox-LDL-mediated inhibition of autophagy in VSMC by inhibiting the PI3K", Akt, PeerJ, pp.2022, 10[DOI]
  23. Zhang Q, "Incomplete autophagy : trouble is a friend", Med Res Rev, 42, pp.1545~1587 (2022)
  24. Martina JA, "MTORC1 functions as a transcriptional regulator of autophagy by preventing nuclear transport of TFEB", Autophagy, 8, pp.903~914 (2012)
  25. Tan A, "Past, present, and future perspectives of transcription factor EB(TFEB) : mechanisms of regulation and association with disease", Cell Death Differ, 29, pp.1433~1449 (2022)
  26. Akhmedov A, "Endothelial LOX-1 activation differentially regulates arterial thrombus formation depending on oxLDL levels : role of the Oct-1", SIRT1 and ERK1, Cardiovasc Res, pp.2017, 113[DOI]
  27. Zhang Z, "Role of lysosomes in physiological activities, diseases, and therapy", J Hematol Oncol, 14, pp.79~ (2021)
  28. Tao J, "Gastrodin induces lysosomal biogenesis and autophagy to prevent the formation of foam cells via AMPK-FoxO1-TFEB signalling axis", J Cell Mol Med, 25, pp.5769~5781 (2021)
  29. Zhou YD, "Rapamycin inhibits oxidized low density lipoprotein uptake in human umbilical vein endothelial cells via mTOR", NF-κB, PLoS One, pp.2016, 11[DOI]
  30. Xu C, "TNF-α-dependent neuronal necroptosis regulated in Alzheimer’s disease by coordination of RIPK1-p62 complex with autophagic UVRAG", Theranostics, 11, pp.9452~9469 (2021)
  31. Karunakaran D, "Targeting macrophage necroptosis for therapeutic and diagnostic interventions in atherosclerosis", Sci Adv, 2, pp.e1600224~ (2016)
  32. Steinl DC, "Ultrasound imaging for risk assessment in atherosclerosis", Int J Mol Sci, 16, pp.9749~9769 (2015)
  33. Hashimoto K, "Lectin-like oxidized low density lipoprotein receptor 1-deficient mice show resistance to instability-induced osteoarthritis", Scand J Rheumatol, 45, pp.412~422 (2016)
  34. de Munter W, "High LDL levels lead to increased synovial inflammation and accelerated ectopic bone formation during experimental osteoarthritis", Osteoarthritis Cartilage, 24, pp.844~855 (2016)
  35. Monetti M, "Rosuvastatin displays anti-atherothrombotic and anti-inflammatory properties in ApoE-deficient mice", Pharmacol Res, 55, pp.441~449 (2007)
  36. Sironi L, "Rosuvastatin, but not simvastatin, provides end-organ protection in stroke-prone rats by antiinflammatory effects", Arterioscler Thromb Vasc Biol, 25, pp.598~603 (2005)
  37. Yudoh K, "Statin prevents chondrocyte aging and degeneration of articular cartilage in osteoarthritis(OA)", Aging(Albany NY), 2, pp.990~998 (2010)
  38. Caramés B, "Autophagy activation by rapamycin reduces severity of experimental osteoarthritis", Ann Rheum Dis, 71, pp.575~581 (2012)
  39. Hall AJ, "Association between osteoarthritis and cardiovascular disease : systematic review and meta-analysis", Eur J Prev Cardiol, 23, pp.938~946 (2016)
  40. Zushi S, "Induction of bovine articular chondrocyte senescence with oxidized low-density lipoprotein through lectin-like oxidized low-density lipoprotein receptor 1", Arthritis Rheum, 60, pp.3007~3016 (2009)
  41. Akagi M, "Oxidized LDL binding to LOX-1 enhances MCP-1 expression in cultured human articular chondrocytes", Osteoarthritis Cartilage, 17, pp.271~275 (2009)
  42. Farnaghi S, "Cholesterol metabolism in pathogenesis of osteoarthritis disease", Int J Rheum Dis, 20, pp.131~140 (2017)
  43. Jin X, "Circulating C reactive protein in osteoarthritis : a systematic review and meta-analysis", Ann Rheum Dis, 74, pp.703~710 (2015)
  44. Nie P, "Analysis of microRNAs associated with carotid atherosclerotic plaque rupture with thrombosis", Front Genet, 12, pp.599350~ (2021)
  45. Herrero-Manley L, "Serum lipid biomarkers and inflammatory cytokines associated with onset and clinical status of patients with early knee osteoarthritis", Front Nutr, 10, pp.1126796~ (2023)

이 간행물의 다른 논문 (7건)

Influenza Virus-Derived CD8 T Cell Epitopes: Implications for the Development of Universal Influenza Vaccines이영란, 박찬수, 김정기, Jihee Oh, 김상현, Erica Españo, Bill Thaddeus Padasas, Ju-Ho Son, Richard J. Webbypp. 1-15The Impact of Pulmonary Disorders on Neurological Health (Lung-Brain Axis)Chan Hee Lee, Hongryeol Parkpp. 1-21IL-1 Receptor Dynamics in Immune Cells: Orchestrating Immune Precision and Balance이원우, 김동현pp. 1-16Exploring the Potential of Glycolytic Modulation in Myeloid-Derived Suppressor Cells for Immunotherapy and Disease Management최지연, 민혜영, 황광우, 김지수pp. 1-19Erratum : Inhibition of Chitinase-3-like-1 by K284-6111 Reduces Atopic Skin Inflammation via Repressing Lactoferrin손동주, 이희범, 이용선, 윤재석, 홍진태, 한상배, 전성희, 예인준pp. 1-1
원문 보기